# AstraZeneca Pharma India reported a 23 per cent decline in net profit to Rs 44.88 crore.

*biotech · news · 2026-05-26 · Devdiscourse*

## Key points

- AstraZeneca Pharma India's Q4 FY26 net profit declined 23% to Rs 44.88 crore.
- Q4 FY26 revenue for AstraZeneca Pharma India rose 20.42% to Rs 578.61 crore.
- Total expenses in Q4 FY26 increased 27.36% to Rs 525.34 crore.
- Full-year FY26 net profit for AstraZeneca Pharma India surged 62% to Rs 187.52 crore.
- Full-year FY26 revenue growth was driven by Oncology, Biopharmaceuticals, and Rare Disease progress.

**Companies:** AstraZeneca
**Countries:** India

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3922635-astrazeneca-pharma-indias-revenue-boost-amid-profit-dip)

---

Canonical: https://newsio.io/n/4a4273e2-55c4-4a31-8f69-385538f99369/astrazeneca-pharma-india-reported-a-23-per-cent-decline-in-net-profit-to-rs-44-8
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works